Mark J. Canet

915 total citations
16 papers, 686 citations indexed

About

Mark J. Canet is a scholar working on Epidemiology, Oncology and Molecular Biology. According to data from OpenAlex, Mark J. Canet has authored 16 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 10 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Mark J. Canet's work include Liver Disease Diagnosis and Treatment (11 papers), Drug Transport and Resistance Mechanisms (10 papers) and Liver Diseases and Immunity (3 papers). Mark J. Canet is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Drug Transport and Resistance Mechanisms (10 papers) and Liver Diseases and Immunity (3 papers). Mark J. Canet collaborates with scholars based in United States, Netherlands and China. Mark J. Canet's co-authors include Nathan J. Cherrington, Rhiannon N. Hardwick, Craig D. Fisher, April D. Lake, John Clarke, George L. Scheffer, Anika L. Dzierlenga, Matthew D. Merrell, Nathan J. Cherrington and Liangyou Rui and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Fertility and Sterility and eLife.

In The Last Decade

Mark J. Canet

15 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark J. Canet United States 15 437 300 169 162 143 16 686
Yuichi Yamazaki Japan 17 460 1.1× 169 0.6× 398 2.4× 233 1.4× 157 1.1× 75 1.0k
Cecilia L. Basiglio Argentina 12 123 0.3× 163 0.5× 101 0.6× 201 1.2× 85 0.6× 18 554
Elena Bellafante Italy 9 269 0.6× 208 0.7× 132 0.8× 214 1.3× 29 0.2× 14 608
Anne S. Henkel United States 15 382 0.9× 137 0.5× 157 0.9× 230 1.4× 36 0.3× 30 827
Len Verbeke Belgium 13 645 1.5× 314 1.0× 557 3.3× 174 1.1× 112 0.8× 23 1.2k
Anna Baghdasaryan Austria 11 348 0.8× 393 1.3× 325 1.9× 109 0.7× 69 0.5× 18 771
Anne Marie Jézéquel Italy 15 436 1.0× 168 0.6× 518 3.1× 271 1.7× 113 0.8× 19 948
Prachi Borude United States 11 352 0.8× 183 0.6× 365 2.2× 268 1.7× 306 2.1× 15 794
Emilia Ip Australia 7 668 1.5× 101 0.3× 163 1.0× 386 2.4× 60 0.4× 14 958
Anne Spraul France 12 250 0.6× 347 1.2× 175 1.0× 93 0.6× 30 0.2× 22 720

Countries citing papers authored by Mark J. Canet

Since Specialization
Citations

This map shows the geographic impact of Mark J. Canet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Canet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Canet more than expected).

Fields of papers citing papers by Mark J. Canet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Canet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Canet. The network helps show where Mark J. Canet may publish in the future.

Co-authorship network of co-authors of Mark J. Canet

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Canet. A scholar is included among the top collaborators of Mark J. Canet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Canet. Mark J. Canet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Xiong, Yi, Adriana Souza Torsoni, Feihua Wu, et al.. (2018). Hepatic NF-kB-inducing kinase (NIK) suppresses mouse liver regeneration in acute and chronic liver diseases. eLife. 7. 30 indexed citations
2.
Li, Hui, Mark J. Canet, John Clarke, et al.. (2017). Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis. Drug Metabolism and Disposition. 45(12). 1317–1325. 20 indexed citations
3.
Chen, Zheng, Mark J. Canet, Liang Sheng, et al.. (2015). Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity. Molecular Metabolism. 4(12). 951–960. 29 indexed citations
4.
Canet, Mark J., Matthew D. Merrell, Rhiannon N. Hardwick, et al.. (2015). Altered Regulation of Hepatic Efflux Transporters Disrupts Acetaminophen Disposition in Pediatric Nonalcoholic Steatohepatitis. Drug Metabolism and Disposition. 43(6). 829–835. 51 indexed citations
5.
Hardwick, Rhiannon N., John Clarke, April D. Lake, et al.. (2014). Increased Susceptibility to Methotrexate-Induced Toxicity in Nonalcoholic Steatohepatitis. Toxicological Sciences. 142(1). 45–55. 48 indexed citations
6.
Clarke, John, Rhiannon N. Hardwick, April D. Lake, Mark J. Canet, & Nathan J. Cherrington. (2014). Experimental Nonalcoholic Steatohepatitis Increases Exposure to Simvastatin Hydroxy Acid by Decreasing Hepatic Organic Anion Transporting Polypeptide Expression. Journal of Pharmacology and Experimental Therapeutics. 348(3). 452–458. 37 indexed citations
7.
Canet, Mark J., Rhiannon N. Hardwick, April D. Lake, et al.. (2014). Modeling Human Nonalcoholic Steatohepatitis-Associated Changes in Drug Transporter Expression Using Experimental Rodent Models. Drug Metabolism and Disposition. 42(4). 586–595. 57 indexed citations
8.
Canet, Mark J., Rhiannon N. Hardwick, April D. Lake, et al.. (2014). Renal Xenobiotic Transporter Expression is Altered in Multiple Experimental Models of Nonalcoholic Steatohepatitis. Drug Metabolism and Disposition. 43(2). 266–272. 14 indexed citations
9.
Canet, Mark J., Matthew D. Merrell, Bryan Harder, et al.. (2014). Identification of a Functional Antioxidant Response Element within the Eighth Intron of the Human ABCC3 Gene. Drug Metabolism and Disposition. 43(1). 93–99. 19 indexed citations
10.
Canet, Mark J. & Nathan J. Cherrington. (2014). Drug disposition alterations in liver disease: extrahepatic effects in cholestasis and nonalcoholic steatohepatitis. Expert Opinion on Drug Metabolism & Toxicology. 10(9). 1209–1219. 22 indexed citations
11.
Canet, Mark J., et al.. (2013). Peroxisome proliferator acivated receptor δ (PPAR δ) activation enhances the development of cryopreserved embryos. Fertility and Sterility. 100(3). S187–S187.
12.
Canet, Mark J., Rhiannon N. Hardwick, April D. Lake, et al.. (2012). Altered Arsenic Disposition in Experimental Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition. 40(9). 1817–1824. 21 indexed citations
13.
Cherrington, Nathan J., et al.. (2012). The hepatic bile acid transporters Ntcp and Mrp2 are downregulated in experimental necrotizing enterocolitis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 304(1). G48–G56. 22 indexed citations
14.
Hardwick, Rhiannon N., et al.. (2011). Molecular Mechanism of Altered Ezetimibe Disposition in Nonalcoholic Steatohepatitis. Drug Metabolism and Disposition. 40(3). 450–460. 52 indexed citations
15.
Hardwick, Rhiannon N., Craig D. Fisher, Mark J. Canet, George L. Scheffer, & Nathan J. Cherrington. (2011). Variations in ATP-Binding Cassette Transporter Regulation during the Progression of Human Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition. 39(12). 2395–2402. 113 indexed citations
16.
Hardwick, Rhiannon N., Craig D. Fisher, Mark J. Canet, April D. Lake, & Nathan J. Cherrington. (2010). Diversity in Antioxidant Response Enzymes in Progressive Stages of Human Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition. 38(12). 2293–2301. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuichi Yamazaki Breakdown of academic impact, for papers by Cecilia L. Basiglio Breakdown of academic impact, for papers by Elena Bellafante Breakdown of academic impact, for papers by Anne S. Henkel Breakdown of academic impact, for papers by Len Verbeke Breakdown of academic impact, for papers by Anna Baghdasaryan Breakdown of academic impact, for papers by Anne Marie Jézéquel Breakdown of academic impact, for papers by Prachi Borude Breakdown of academic impact, for papers by Emilia Ip Breakdown of academic impact, for papers by Anne Spraul
Rankless by CCL
2026